Kirk Brown in

Kirk Brown

Login to view DISC.
Vice President, Research at Alnylam Pharmaceuticals
📍 Cambridge, Massachusetts, United States

Kirk Brown is the Vice President of Research at Alnylam Pharmaceuticals, where he leads the Central Nervous System (CNS) research group. With a Ph. D. from the University of Vermont, he has risen through the ranks at Alnylam, spearheading the development of RNAi therapeutics for neurological diseases.

His teams preclinical work was instrumental in delivering RNAi therapeutics to the brain, leading to Alnylams first clinical program for the CNS.

Read the full overview →
Experience
20 Years
Current Role
Vice President, Research
Job Level
Senior
Location
Cambridge, Massachusetts, United States
Personality Overview

How Kirk shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Kirk cares about

CNS Drug Development
He leads the CNS research team and is the research lead for ALN-APP, the first clinical CNS RNAi therapeutic program at Alnylam.
RNAi Therapeutics
His entire focus is on advancing Alnylam's core RNAi platform, specifically finding innovative ways to apply it to previously hard-to-reach tissues like the brain.
+4 more topics Login to view topics
Career

Work history

8-2023
Vice President, Research
Alnylam Pharmaceuticals
4-2021 - 7-2023
Senior Director, CNS Research
Alnylam Pharmaceuticals
2-2019 - 3-2021
Director, CNS Early Development
Alnylam Pharmaceuticals
7-2017 - 1-2019
Associate Director
Alnylam Pharmaceuticals
3-2016 - 6-2017
Principal Scientist
Alnylam Pharmaceuticals
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2003 - 2005
Post-Doctoral Fellow
UMass Chan Medical School
1997 - 2003
Ph.D
University of Vermont
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Alnylam Pharmaceuticals Employees

Explore more public profiles from related professionals.

Sharon Haynes Meakin, Ph.D.
Sharon Haynes Meakin, Ph.D.
Director, Head of Global Medical Affairs Training
Alnylam Pharmaceuticals
 Garrett Ingrando
Garrett Ingrando
Head of Marketing for North America
Alnylam Pharmaceuticals

More profiles

Discover additional public profiles from our index.

Elizabeth Hetrick
Elizabeth Hetrick
Director, IT Business Relationship Management for Laboratory Operations
Exact Sciences
 Elian Lee
Elian Lee
Director, Early Research
Twist Bioscience
 Daniel Kaiser
Daniel Kaiser
Associate Director, Enterprise Architecture
Exact Sciences
 Lance Burchett
Lance Burchett
Vice President for Advancement and CEO of the KSU Foundation
Kennesaw State University
Unlock the full playbookSee exactly how to sell to Kirk. Free, 10 seconds.